Cancer Pathology & Biomarkers

Cancer diagnosis and prognosis are evolving through the identification of novel biomarkers and molecular subtyping. This track investigates morphological and molecular features in common and rare malignancies, emphasizing diagnostic accuracy and reproducibility. Topics include tumor heterogeneity, immunohistochemical markers, and molecular signatures with clinical utility. Sessions cover advances in digital pathology applications, such as AI-assisted scoring and quantification of biomarkers like PD-L1, HER2, and Ki-67. The role of pathology in early detection, minimal residual disease monitoring, and predicting therapeutic responses forms a cornerstone of discussion. Emphasis is placed on harmonizing diagnostic criteria and guidelines to improve patient management and outcomes.

    Related Conference of Cancer Pathology & Biomarkers

    December 11-12, 2025

    6th International Conference on Breast Pathology and Cancer Diagnosis

    Amsterdam, Netherlands
    March 26-27, 2026

    24th Annual Pathology Congress

    Dubai, UAE
    June 22-23, 2026

    24th European Pathology Congress

    Paris, France

    Cancer Pathology & Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in